COVID-19: a Novel Risk Factor for Perioperative Neurocognitive Disorders
Penghui Wei,Wenyuan Lyu,Tian-Tian Wan,Qiang Zheng,Wenxi Tang,Jianjun Li,Jianjun Yang
DOI: https://doi.org/10.1016/j.bja.2021.06.016
IF: 11.719
2021-01-01
British Journal of Anaesthesia
Abstract:Editor—Older patients with current or previous SARS-CoV-2 infection (COVID-19) have been undergoing surgical interventions at an increasing rate during the COVID-19 pandemic and face a high risk of postoperative complications. Most older patients are expected to recover from acute postoperative complications, including most pulmonary and renal complications and delirium. Recently, a national database study on hip fracture characteristics and outcomes during the COVID-19 pandemic in the USA showed that older patients with hip fracture and concomitant COVID-19 experienced significantly higher rates of acute postoperative complications, especially pulmonary complications (22.9%).1Zhong H. Poeran J. Liu J. Wilson L.A. Memtsoudis S.G. Hip fracture characteristics and outcomes during COVID-19: a large retrospective national database review.Br J Anaesth. 2021; 127: 15-22Abstract Full Text Full Text PDF PubMed Scopus (26) Google Scholar However, long-term neurological sequelae, such as perioperative neurocognitive disorders (PNDs), commonly occurring in older patients after major noncardiac surgery (incidence as high as 40%),2Wiles M.D. Should cognitive impairment be an exclusion criterion for hip fracture studies?.Br J Anaesth. 2013; 111: 514Abstract Full Text Full Text PDF PubMed Scopus (2) Google Scholar,3Monk T.G. Weldon B.C. Garvan C.W. et al.Predictors of cognitive dysfunction after major noncardiac surgery.Anesthesiology. 2008; 108: 18-30Crossref PubMed Scopus (1163) Google Scholar have received relatively little attention. PNDs that encompass acute postoperative delirium and longer-lasting postoperative cognitive dysfunction are age-related neurological disorders and are associated with dementia.4Subramaniyan S. Terrando N. Neuroinflammation and perioperative neurocognitive disorders.Anesth Analg. 2019; 128: 781-788Crossref PubMed Scopus (230) Google Scholar Older patients with a PND have a significantly increased mortality 3 months after surgery and are at risk for a higher rate of disability, leading to loss of employment, which may lead to a greater reliance on social security.5Steinmetz J. Christensen K.B. Lund T. Lohse N. Rasmussen L.S. ISPOCD GroupLong-term consequences of postoperative cognitive dysfunction.Anesthesiology. 2009; 110: 548-555Crossref PubMed Scopus (797) Google Scholar Interestingly, the enhanced expression of angiotensin-converting enzyme-2 (ACE-2) receptors in the CNS of patients with dementia may make them more susceptible to COVID-19 (Fig. 1).6Ding Q. Shults N.V. Harris B.T. Suzuki Y.J. Angiotensin-converting enzyme 2 (ACE2) is upregulated in Alzheimer's disease brain.bioRxiv. October 8 2020; https://doi.org/10.1101/2020.10.08.331157Crossref Scopus (0) Google Scholar,7Ciaccio M. Lo Sasso B. Scazzone C. et al.COVID-19 and Alzheimer's disease.Brain Sci. 2021; 11: 305Crossref PubMed Scopus (73) Google Scholar Clinical studies have identified advanced age, major surgery, low educational level, history of alcohol or opioid use, anticholinergic medication, and pre-existing cognitive impairment as important risk factors for PND.3Monk T.G. Weldon B.C. Garvan C.W. et al.Predictors of cognitive dysfunction after major noncardiac surgery.Anesthesiology. 2008; 108: 18-30Crossref PubMed Scopus (1163) Google Scholar,8Skvarc D.R. Berk M. Byrne L.K. et al.Post-operative cognitive dysfunction: an exploration of the inflammatory hypothesis and novel therapies.Neurosci Biobehav Rev. 2018; 84: 116-133Crossref PubMed Scopus (204) Google Scholar The COVID-19 pandemic has significantly affected the epidemiological characteristics of many diseases, and COVID-19 must be considered a potential risk factor for acute or chronic neurological complications because the causative virus, SARS-CoV-2, is more invasive in the CNS than other coronaviruses.9Amruta N. Chastain W.H. Paz M. et al.SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders.Cytokine Growth Factor Rev. 2021; 58: 1-15Crossref PubMed Scopus (76) Google Scholar,10Hosseini N. Nadjafi S. Ashtary B. Overview of COVID-19 and neurological complications.Rev Neurosci. February 15 2021; https://doi.org/10.1515/revneuro-2020-0116Crossref PubMed Scopus (12) Google Scholar Acute neurological symptoms associated with COVID-19, including confusion, headache, hypogeusia, hyposmia, and seizures, provide evidence of direct invasion by SARS-CoV-2 into the CNS. Most patients with COVID-19 fully resolve from these acute symptoms after clinical recovery.7Ciaccio M. Lo Sasso B. Scazzone C. et al.COVID-19 and Alzheimer's disease.Brain Sci. 2021; 11: 305Crossref PubMed Scopus (73) Google Scholar However, a small observational study showed that 33% of patients with severe COVID-19 experienced cognitive and motor dysfunction, including inattention, disorientation, and poorly organised movements in response to command, even after hospital discharge.11Helms J. Kremer S. Merdji H. et al.Neurologic features in severe SARS-CoV-2 infection.N Engl J Med. 2020; 382: 2268-2270Crossref PubMed Scopus (1846) Google Scholar Long-term neurological disorders have been observed in non-critical patients with COVID-19 as well, although results are yet to be completed.12Baker H.A. Safavynia S.A. Evered L.A. The 'third wave': impending cognitive and functional decline in COVID-19 survivors.Br J Anaesth. 2021; 126: 44-47Abstract Full Text Full Text PDF PubMed Scopus (65) Google Scholar Moreover, COVID-19 may promote the initiation and progression of age-related progressive neurodegenerative conditions, such as Alzheimer's disease (AD). Preliminary observations have revealed that COVID-19 causes worsening of behavioural symptoms and potential gradual aggravation of the underlying AD neuropathologies and related dementia, which may take months or years to detect.13Cohen G. Russo M.J. Campos J.A. Allegri R.F. COVID-19 epidemic in Argentina: worsening of behavioral symptoms in elderly subjects with dementia living in the community.Front Psychiatry. 2020; 11: 866Crossref PubMed Scopus (57) Google Scholar, 14Daugherty A.M. Chopra T. Korzeniewski S.J. Levy P. COVID-19 as a risk factor for Alzheimer's disease and related dementia: a perspective from Detroit, MI.Psychiatry Res. 2020; 294: 113557Crossref PubMed Scopus (8) Google Scholar, 15Hascup E.R. Hascup K.N. Does SARS-CoV-2 infection cause chronic neurological complications?.GeroScience. 2020; 42: 1083-1087Crossref PubMed Scopus (52) Google Scholar Support for a relationship between age-related neurodegenerative conditions and COVID-19 has yet to be reported because of the recent origin of the pandemic. Anaesthesia and surgery can disrupt the integrity of the blood–brain barrier (BBB) and facilitate migration of peripheral innate immune molecules into the hippocampus, and SARS-CoV-2 infection may accelerate this process.16Baig A.M. Khaleeq A. Ali U. Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms.ACS Chem Neurosci. 2020; 11: 995-998Crossref PubMed Scopus (1522) Google Scholar,17Eckenhoff R.G. Maze M. Xie Z. et al.Perioperative neurocognitive disorder: state of the preclinical science.Anesthesiology. 2020; 132: 55-68Crossref PubMed Scopus (106) Google Scholar Neurotoxicity via ACE-2 receptors in the hippocampus can be caused by SARS-CoV-2 via its access to the CNS through retrograde axonal transport along the olfactory bulb or disrupted BBB (Fig. 1).7Ciaccio M. Lo Sasso B. Scazzone C. et al.COVID-19 and Alzheimer's disease.Brain Sci. 2021; 11: 305Crossref PubMed Scopus (73) Google Scholar,9Amruta N. Chastain W.H. Paz M. et al.SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders.Cytokine Growth Factor Rev. 2021; 58: 1-15Crossref PubMed Scopus (76) Google Scholar SARS-CoV-2-mediated immune responses can also play a critical role in cognitive impairment through indirect CNS involvement. Furthermore, the molecular mechanisms, including significant neuroinflammation, mitochondrial oxidative stress, and accumulation of amyloid beta (Aβ), of SARS-CoV-2-induced cognitive disorders are similar to those of PNDs (Fig. 1).7Ciaccio M. Lo Sasso B. Scazzone C. et al.COVID-19 and Alzheimer's disease.Brain Sci. 2021; 11: 305Crossref PubMed Scopus (73) Google Scholar,8Skvarc D.R. Berk M. Byrne L.K. et al.Post-operative cognitive dysfunction: an exploration of the inflammatory hypothesis and novel therapies.Neurosci Biobehav Rev. 2018; 84: 116-133Crossref PubMed Scopus (204) Google Scholar Surgical trauma can trigger complement signalling activation in the CNS and subsequently activate microglia via CD11b signalling, which further increases SARS-CoV-2-mediated neuroinflammation.9Amruta N. Chastain W.H. Paz M. et al.SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders.Cytokine Growth Factor Rev. 2021; 58: 1-15Crossref PubMed Scopus (76) Google Scholar,18Yang T. Velagapudi R. Terrando N. Neuroinflammation after surgery: from mechanisms to therapeutic targets.Nat Immunol. 2020; 21: 1319-1326Crossref PubMed Scopus (110) Google Scholar A recent editorial suggested a correlation between PND and cognitive disorders associated with SARS-CoV-2 because of their overlapping inflammatory response to injury.12Baker H.A. Safavynia S.A. Evered L.A. The 'third wave': impending cognitive and functional decline in COVID-19 survivors.Br J Anaesth. 2021; 126: 44-47Abstract Full Text Full Text PDF PubMed Scopus (65) Google Scholar The authors stated that it may be beneficial to alleviate long-term neurological consequences of COVID-19 by implementing preventive interventions or treatments before surgery and anaesthesia, which could improve pre-existing poor cognitive and functional outcomes for patients with COVID-19. Increasing evidence suggests that mitochondrial dysfunction is involved in both PND and COVID-19.8Skvarc D.R. Berk M. Byrne L.K. et al.Post-operative cognitive dysfunction: an exploration of the inflammatory hypothesis and novel therapies.Neurosci Biobehav Rev. 2018; 84: 116-133Crossref PubMed Scopus (204) Google Scholar,19Ganji R. Reddy P.H. Impact of COVID-19 on mitochondrial-based immunity in aging and age-related diseases.Front Aging Neurosci. 2020; 12: 614650Crossref PubMed Scopus (74) Google Scholar SARS-CoV-2 can enter cells via the ACE-2 receptor and affect mitochondria, causing increased fusion and excess production of reactive oxygen species, thereby damaging mitochondrial DNA and accelerating CNS oxidative stress.19Ganji R. Reddy P.H. Impact of COVID-19 on mitochondrial-based immunity in aging and age-related diseases.Front Aging Neurosci. 2020; 12: 614650Crossref PubMed Scopus (74) Google Scholar Additionally, reports have suggested a critical role of Aβ accumulation in the brain in PND.20Xie Z. McAuliffe S. Swain C.A. et al.Cerebrospinal fluid Aβ to tau ratio and postoperative cognitive change.Ann Surg. 2013; 258: 364-369Crossref PubMed Scopus (0) Google Scholar SARS-CoV-2 neuroinvasion could promote endothelial dysfunction and loss of pericytes (disrupted BBB), which can impair Aβ clearance and lead to excess Aβ generation in the hippocampus.7Ciaccio M. Lo Sasso B. Scazzone C. et al.COVID-19 and Alzheimer's disease.Brain Sci. 2021; 11: 305Crossref PubMed Scopus (73) Google Scholar,16Baig A.M. Khaleeq A. Ali U. Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms.ACS Chem Neurosci. 2020; 11: 995-998Crossref PubMed Scopus (1522) Google Scholar SARS-CoV-2 infection could directly induce Aβ generation in the CNS as part of the immune response; however, this hypothesis needs to be tested further.7Ciaccio M. Lo Sasso B. Scazzone C. et al.COVID-19 and Alzheimer's disease.Brain Sci. 2021; 11: 305Crossref PubMed Scopus (73) Google Scholar Taken together, COVID-19 may potentially lead to an accelerated cognitive decline associated with anaesthesia and surgical stress through independent and synergistic mechanisms. COVID-19 soon could be recognised as a long-term risk factor for accelerated onset or deterioration of PND in the ageing population undergoing surgery. Future clinical research needs to consider COVID-19 as a potential risk factor for PND in the post-COVID-19 era. Long-term prospective longitudinal studies in older patients undergoing surgery and anaesthesia with concomitant or previous COVID-19 diagnosis should be designed to determine the effect of COVID-19 on the pathological progression of PND and other age-related dementias. The authors declare that they have no conflicts of interest. Natural Science Foundation of Shandong Province (ZR2020QH291 and ZR2020MH126); Key Research and Development Plan of Shandong Province (2019GSF108228); Qingdao Key Health Discipline Development Fund (2019); Qingdao Outstanding Health Professional Development Fund (2019); Scientific Research Foundation of Qilu Hospital of Shandong University (Qingdao), China (QDKY2018QN12 and QDKY2019YC06).